These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32534047)

  • 1. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery.
    Liu Y; Xie X; Chen H; Hou X; He Y; Shen J; Shi J; Feng N
    Nanomedicine; 2020 Oct; 29():102237. PubMed ID: 32534047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Application of Polymer Nanocarriers in Delivery of Active Ingredients from Traditional Chinese Medicines.
    Zhai Z; Niu J; Xu L; Xu J
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative choice of lidocaine-loaded liposomes: lidocaine-loaded lipid-polymer hybrid nanoparticles for local anesthetic therapy.
    Wang J; Zhang L; Chi H; Wang S
    Drug Deliv; 2016 May; 23(4):1254-60. PubMed ID: 26881926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM).
    Liu Y; Feng N
    Adv Colloid Interface Sci; 2015 Jul; 221():60-76. PubMed ID: 25999266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of psoralen-loaded lipid-polymer hybrid nanoparticles and their reversal effect on drug resistance of cancer cells.
    Yuan Y; Chiba P; Cai T; Callaghan R; Bai L; Cole SPC; Cai Y
    Oncol Rep; 2018 Aug; 40(2):1055-1063. PubMed ID: 29901161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin-Assisted Method Allows Assessment of Release of Hydrophobic Drugs From Nanocarriers.
    Gil D; Frank-Kamenetskii A; Barry J; Reukov V; Xiang Y; Das A; Varma AK; Kindy MS; Banik NL; Vertegel A
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28881095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-lipid hybrid systems used as carriers for insulin delivery.
    Grigoras AG
    Nanomedicine; 2017 Nov; 13(8):2425-2437. PubMed ID: 28821465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.
    Mukherjee A; Waters AK; Kalyan P; Achrol AS; Kesari S; Yenugonda VM
    Int J Nanomedicine; 2019; 14():1937-1952. PubMed ID: 30936695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
    Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.
    Bose RJC; Ravikumar R; Karuppagounder V; Bennet D; Rangasamy S; Thandavarayan RA
    Drug Discov Today; 2017 Aug; 22(8):1258-1265. PubMed ID: 28600191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.